Supraventricular tachycardia in an infant

Area of Science:

• Pediatric Cardiology
• Emergency Medicine
• Pharmacology

Background:

• Supraventricular tachycardia (SVT) is a common cardiac arrhythmia in infants.
• Vagal maneuvers are the first line of treatment for pediatric SVT.
• Adenosine is an antiarrhythmic drug used for SVT in adults.

Observation:

• A 1-month-old infant diagnosed with SVT was treated with adenosine.
• The treatment was administered due to failure of vagal maneuvers.
• The infant's response to adenosine was closely monitored.

Findings:

• Adenosine administration was extremely effective in terminating the infant's SVT.
• No observable adverse side effects were noted in the patient post-administration.
• The infant tolerated the medication well, indicating a positive safety profile in this case.

Implications:

• Adenosine demonstrates significant potential as a safe and effective treatment for infant SVT.
• Emergency nurses should be knowledgeable about adenosine protocols for pediatric SVT.
• Further clinical studies are warranted to establish comprehensive guidelines for adenosine use in pediatric populations.